MedPath

To Prevention of postpartum hemorrhage (bleeding after giving birth)in caesarean section by comparing 2 drugs that are carbetocin and oxytocin efficacy.

Phase 4
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indication
Registration Number
CTRI/2024/03/063620
Lead Sponsor
Pacific medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Healthy women with term gestation irrespective of parity

Singleton pregnancy

Live baby

Delivery by LSCS

Any presentation

Exclusion Criteria

Twin pregnancy

Intrauterine death

Preeclampsia (PIH)

Women with medical illness

Rh incompabalitiy

Any type of vaginal bleeding like placenta Previn, abruption placenta etc

Abnormal placentation

Hypersensitivity to carbetocin or oxytocin or misoprostol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the oxytocin and carbetocin regarding effectiveness, safety during caesarean sections in women of pph <br/ ><br>As carbetocin has longer half life compared to oxytocin so carbetocin is betterTimepoint: 1 yrs
Secondary Outcome Measures
NameTimeMethod
To compare the safety of carbetocin versus oxytocin in terms of adverse drug reaction <br/ ><br>To compare the fall in haemoglobin level & Haematocrit levelTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath